Determinants of metabolic dysfunction associated steatotic liver disease and liver fibrosis in patients with type 2 diabetes mellitus: a cross-sectional study

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD), is today the leading cause of chronic liver conditions in the context of a global epidemic of obesity and metabolic disorders. Our study aims to determine the preval...

Полное описание

Библиографические подробности

Главные авторы:	Soumaya Mrabet, Ghada Saad, Asma Ben cheikh, Mohamed Abu Awad, Imen Halloul, Raida Harbi, Meryam Eloillaf, Imen Akkari, Yosra Hasni, Elhem Ben Jazia
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-07-01
Серии:	Frontiers in Medicine
Предметы:	fibroscan hepatic steatosis liver fibrosis MASH MASLD type 2 diabetes mellitus
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1863576/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!